Bmi-1 expression modulates non-small cell lung cancer progression

References

• Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ. Cancer statistics, 2009. CA Cancer J Clin 2009; 59(4):225-49; PMID:19474385
   PubMed Web of Science ®Google Scholar
• Sone S, Yano S. Molecular pathogenesis and its therapeutic modalities of lung cancer metastasis to bone. Cancer Metast Rev 2007; 26(3-4):685-9; http://dx.doi.org/10.1007/s10555-007-9081-z
   PubMed Web of Science ®Google Scholar
• Bracken AP, Helin K. Polycomb group proteins: navigators of lineage pathways led astray in cancer. Nat Rev Cancer 2009; 9(11):773-84; PMID:19851313; http://dx.doi.org/10.1038/nrc2736
   PubMed Web of Science ®Google Scholar
• Siddique HR, Saleem M. Role of BMI1, a stem cell factor, in cancer recurrence and chemoresistance: preclinical and clinical evidences. Stem Cell 2012; 30(3):372-8; PMID:22252887; http://dx.doi.org/10.1002/stem.1035
   PubMed Web of Science ®Google Scholar
• Haupt Y, Alexander WS, Barri G, Klinken SP, Adams JM. Novel zinc finger gene implicated as myc collaborator by retrovirally accelerated lymphomagenesis in E mu-myc transgenic mice. Cell 1991; 65(5):753-63; PMID:1904009; http://dx.doi.org/10.1016/0092-8674(91)90383-A
   PubMed Web of Science ®Google Scholar
• van Lohuizen M, Verbeek S, Scheijen B, Wientjens E, van der Gulden H, Berns A. Identification of cooperating oncogenes in E mu-myc transgenic mice by provirus tagging. Cell 1991; 65(5):737-52; PMID:1904008; http://dx.doi.org/10.1016/0092-8674(91)90382-9
   PubMed Web of Science ®Google Scholar
• Valk-Lingbeek ME, Bruggeman SW, van Lohuizen M. Stem cells and cancer; the polycomb connection. Cell 2004; 118(4):409-18; PMID:15315754; http://dx.doi.org/10.1016/j.cell.2004.08.005
   PubMed Web of Science ®Google Scholar
• Vrzalikova K, Skarda J, Ehrmann J, Murray PG, Fridman E, Kopolovic J, Knizetova P, Hajduch M, Klein J, Kolek V et al. Prognostic value of Bmi-1 oncoprotein expression in NSCLC patients: a tissue microarray study. J Cancer Res Clin Oncol 2008; 134(9):1037-42; PMID:18264721; http://dx.doi.org/10.1007/s00432-008-0361-y
   PubMed Web of Science ®Google Scholar
• Hu J, Liu YL, Piao SL, Yang DD, Yang YM, Cai L. Expression patterns of USP22 and potential targets BMI-1, PTEN, p-AKT in non-small-cell lung cancer. Lung Cancer 2012; 77(3):5939; PMID:22717106; http://dx.doi.org/10.1016/j.lungcan.2012.05.112
   PubMed Web of Science ®Google Scholar
• Zhang X, Sun J, Wang H, Lou Y, Zhang Y, Sha H, Feng J, Han B. IGF-1R and Bmi-1 expressions in lung adenocarcinoma and their clinicopathologic and prognostic significance. Tumour Biol 2014; 35(1):739-45; PMID:23990442; http://dx.doi.org/10.1007/s13277-013-1100-9
   PubMed Web of Science ®Google Scholar
• Kikuchi J, Kinoshita I, Shimizu Y, Kikuchi E, Konishi J, Oizumi S, Kaga K, Matsuno Y, Nishimura M, Dosaka-Akita H. Distinctive expression of the polycomb group proteins Bmi1 polycomb ring finger oncogene and enhancer of zeste homolog 2 in nonsmall cell lung cancers and their clinical and clinicopathologic significance. Cancer 2010; 116(12):3015-24; PMID:20564407; http://dx.doi.org/10.1002/cncr.25128
   PubMed Web of Science ®Google Scholar
• Thiery JP, Sleeman JP. Complex networks orchestrate epithelial-mesenchymal transitions. Nat Rev Mol Cell Biol 2006; 7(2):131-42; PMID:16493418; http://dx.doi.org/10.1038/nrm1835
   PubMed Web of Science ®Google Scholar
• Huber MA, Kraut N, Beug H. Molecular requirements for epithelial-mesenchymal transition during tumor progression. Curr Opin Cell Biol 2005; 17(5):548-58; PMID:16098727; http://dx.doi.org/10.1016/j.ceb.2005.08.001
   PubMed Web of Science ®Google Scholar
• Zheng X, Wang Y, Liu B, Liu C, Liu D, Zhu J, Yang C, Yan J, Liao X, Meng X. Bmi-1-shRNA inhibits the proliferation of lung adenocarcinoma cells by blocking the G1/S phase through decreasing cyclin D1 and increasing p21/p27 levels. NuclAacid Ther 2014; 24(3):210-6; PMID:24552182; http://dx.doi.org/10.1089/nat.2013.0459
   PubMed Web of Science ®Google Scholar
• Breuer RH, Snijders PJ, Smit EF, Sutedja TG, Sewalt RG, Otte AP, van Kemenade FJ, Postmus PE, Meijer CJ, Raaphorst FM. Increased expression of the EZH2 polycomb group gene in BMI-1-positive neoplastic cells during bronchial carcinogenesis. Neoplasia 2004; 6(6):736-43; PMID:15720799; http://dx.doi.org/10.1593/neo.04160
   PubMed Web of Science ®Google Scholar
• Guo BH, Feng Y, Zhang R, Xu LH, Li MZ, Kung HF, Song LB, Zeng MS. Bmi-1 promotes invasion and metastasis, and its elevated expression is correlated with an advanced stage of breast cancer. Mol Cancer 2011; 10(1):10; http://dx.doi.org/10.1186/1476-4598-10-10
   PubMed Web of Science ®Google Scholar
• Becker M, Korn C, Sienerth AR, Voswinckel R, Luetkenhaus K, Ceteci F, Rapp UR. Polycomb group protein Bmi1 is required for growth of RAF driven non-small-cell lung cancer. PloS One 2009; 4(1):e4230; PMID:19156217; http://dx.doi.org/10.1371/journal.pone.0004230
   PubMedGoogle Scholar
• Gupta GP, Massague J. Cancer metastasis: building a framework. Cell 2006; 127(4):679-95; PMID:17110329; http://dx.doi.org/10.1016/j.cell.2006.11.001
   PubMed Web of Science ®Google Scholar
• Steeg PS. Tumor metastasis: mechanistic insights and clinical challenges. Nat Med 2006; 12(8):895-904; PMID:16892035; http://dx.doi.org/10.1038/nm1469
   PubMed Web of Science ®Google Scholar
• Valastyan S, Weinberg RA. Tumor metastasis: molecular insights and evolving paradigms. Cell 2011; 147(2):275-92; PMID:22000009; http://dx.doi.org/10.1016/j.cell.2011.09.024
   PubMed Web of Science ®Google Scholar
• Pantel K, Brakenhoff RH. Dissecting the metastatic cascade. Nat Rev Cancer 2004; 4(6):448-56; PMID:15170447; http://dx.doi.org/10.1038/nrc1370
   PubMed Web of Science ®Google Scholar
• Yang MH, Hsu DS, Wang HW, Wang HJ, Lan HY, Yang WH, Huang CH, Kao SY, Tzeng CH, Tai SK et al. Bmi1 is essential in Twist1-induced epithelial-mesenchymal transition. Nat Cell Biol 2010; 12(10):982-92; PMID:20818389; http://dx.doi.org/10.1038/ncb2099
   PubMed Web of Science ®Google Scholar
• Song LB, Li J, Liao WT, Feng Y, Yu CP, Hu LJ, Kong QL, Xu LH, Zhang X, Liu WL et al. The polycomb group protein Bmi-1 represses the tumor suppressor PTEN and induces epithelial-mesenchymal transition in human nasopharyngeal epithelial cells. J Clin Invest 2009; 119(12):3626-36; PMID:19884659; http://dx.doi.org/10.1172/JCI39374
   PubMed Web of Science ®Google Scholar
• Li X, Yang Z, Song W, Zhou L, Li Q, Tao K, Zhou J, Wang X, Zheng Z, You N et al. Overexpression of Bmi-1 contributes to the invasion and metastasis of hepatocellular carcinoma by increasing the expression of matrix metalloproteinase (MMP)2, MMP-9 and vascular endothelial growth factor via the PTEN/PI3K/Akt pathway. Int J Oncol 2013; 43(3):793-802; PMID:23807724
   PubMed Web of Science ®Google Scholar
• Choi YJ, Choi YL, Cho EY, Shin YK, Sung KW, Hwang YK, Lee SJ, Kong G, Lee JE, Kim JS et al. Expression of Bmi-1 protein in tumor tissues is associated with favorable prognosis in breast cancer patients. Breast Cancer Res Treat 2009; 113(1):83-93; PMID:18228133; http://dx.doi.org/10.1007/s10549-008-9909-4
   PubMed Web of Science ®Google Scholar
• Meng X, Wang Y, Zheng X, Liu C, Su B, Nie H, Zhao B, Zhao X, Yang H. shRNA-mediated knockdown of Bmi-1 inhibit lung adenocarcinoma cell migration and metastasis. Lung Cancer 2012; 77(1):24-30; PMID:22420951; http://dx.doi.org/10.1016/j.lungcan.2012.02.015
   PubMed Web of Science ®Google Scholar
• Song LB, Zeng MS, Liao WT, Zhang L, Mo HY, Liu WL, Shao JY, Wu QL, Li MZ, Xia YF et al. Bmi-1 is a novel molecular marker of nasopharyngeal carcinoma progression and immortalizes primary human nasopharyngeal epithelial cells. Cancer Res 2006; 66(12):6225-32; PMID:16778197; http://dx.doi.org/10.1158/0008-5472.CAN-06-0094
   PubMed Web of Science ®Google Scholar
• Guo WJ, Datta S, Band V, Dimri GP. Mel-18, a polycomb group protein, regulates cell proliferation and senescence via transcriptional repression of Bmi-1 and c-Myc oncoproteins. Mol Biol Cell 2007; 18(2):536-46; PMID:17151361; http://dx.doi.org/10.1091/mbc.E06-05-0447
   PubMed Web of Science ®Google Scholar
• Dimri GP, Martinez JL, Jacobs JJ, Keblusek P, Itahana K, Van Lohuizen M, Campisi J, Wazer DE, Band V. The Bmi-1 oncogene induces telomerase activity and immortalizes human mammary epithelial cells. Cancer Res 2002; 62(16):4736-45; PMID:12183433
   PubMed Web of Science ®Google Scholar
• Zheng J, Wang J, Sun X, Hao M, Ding T, Xiong D, Wang X, Zhu Y, Xiao G, Cheng G et al. HIC1 modulates prostate cancer progression by epigenetic modification. Clin Cancer Res 2013; 19(6):1400-10; PMID:23340301; http://dx.doi.org/10.1158/1078-0432.CCR-12-2888
   PubMed Web of Science ®Google Scholar